Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6515
    -0.0003 (-0.05%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • Bitcoin AUD

    107,745.18
    -700.17 (-0.65%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6036
    +0.0002 (+0.03%)
     
  • AUD/NZD

    1.0896
    -0.0006 (-0.06%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     

Global Opioids Market Trajectory & Analytics Report 2021-2027 Featuring Egalet, Janssen Pharma, Pfizer, Purdue Pharma, Sanofi, Sun Pharma, West-Ward Pharma

Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Opioids - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Opioids Market to Reach $31.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Opioids estimated at US$25.4 Billion in the year 2020, is projected to reach a revised size of US$31.9 Billion by 2027, growing at a CAGR of 3.3% over the period 2020-2027.

Immediate-Release/Short-Acting Opioid, one of the segments analyzed in the report, is projected to record 2.5% CAGR and reach US$16 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Extended-Release/Long-Acting Opioid segment is readjusted to a revised 4.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.9 Billion, While China is Forecast to Grow at 5.9% CAGR

The Opioids market in the U.S. is estimated at US$6.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 2.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Select Competitors (Total 31 Featured):

  • Egalet Corporation

  • Janssen Pharmaceuticals, Inc.

  • Pfizer, Inc.

  • Purdue Pharma LP

  • Sanofi

  • Sun Pharmaceutical Industries Ltd.

  • West-Ward Pharmaceuticals Corporation

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

ADVERTISEMENT

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • United States

  • Canada

  • Japan

  • China

  • Europe

  • France

  • Germany

  • Italy

  • United Kingdom

  • Spain

  • Russia

  • Rest Of Europe

  • Asia-Pacific

  • Australia

  • India

  • South Korea

  • Rest Of Asia-Pacific

  • Latin America

  • Argentina

  • Brazil

  • Mexico

  • Rest Of Latin America

  • Middle East

  • Iran

  • Israel

  • Saudi Arabia

  • United Arab Emirates

  • Rest Of Middle East

  • Africa

IV. COMPETITION

  • Total Companies Profiled: 31

For more information about this report visit https://www.researchandmarkets.com/r/doz5w6

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900